The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Population and evolutionary dynamics of phage therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE GROWTH OF BACTERIAL CULTURES
Monod, J. (1949) · Annual Review of Microbiology · doi:10.1146/annurev.mi.03.100149.002103 · Cited by 3,707
Adams, M. H. (1959) · Interscience Publishers eBooks · doi:10.5962/bhl.title.6966 · Cited by 2,097
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES.
Twort, F. W. (1915) · The Lancet · doi:10.1016/s0140-6736(01)20383-3 · Cited by 901
Antagonistic coevolution between a bacterium and a bacteriophage
Buckling, A., & Rainey, P. B. (2002) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2001.1945 · Cited by 638
Linking genetic change to community evolution: insights from studies of bacteria and bacteriophage
Bohannan, B. J. M., & Lenski, R. E. (2000) · Ecology Letters · doi:10.1046/j.1461-0248.2000.00161.x · Cited by 529
Smith, H. W., & Huggins, M. B. (1982) · Microbiology · doi:10.1099/00221287-128-2-307 · Cited by 518
Long-circulating bacteriophage as antibacterial agents.
Merril, C. R., Biswas, B., Carlton, R., Jensen, N. C., Creed, G. J., Zullo, S., & Adhya, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3188 · Cited by 512
Levin, B. R., Stewart, F. M., & Chao, L. (1977) · The American Naturalist · doi:10.1086/283134 · Cited by 483
Self-citationSummers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Cited by
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 998
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
Oechslin, F. (2018) · Viruses · doi:10.3390/v10070351 · Cited by 594
Importance of prophages to evolution and virulence of bacterial pathogens
Fortier, L.-C., & Sekulovic, O. (2013) · Virulence · doi:10.4161/viru.24498 · Cited by 577
Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth
Hyman, P. (2019) · Pharmaceuticals · doi:10.3390/ph12010035 · Cited by 546
Bacteria-Phage Antagonistic Coevolution in Soil
Gómez, P., & Buckling, A. (2011) · Science · doi:10.1126/science.1198767 · Cited by 495
Antibiotics in Aquaculture – Use, Abuse and Alternatives
Romero, J., Gloria, C., & Navarrete, P. (2012) · Health and Environment in Aquaculture · doi:10.5772/28157 · Cited by 489
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Post weaning diarrhea in pigs: risk factors and non-colistin-based control strategies
Rhouma, M., Fairbrother, J. M., Beaudry, F., & Letellier, A. (2017) · Acta Veterinaria Scandinavica · doi:10.1186/s13028-017-0299-7 · Cited by 454
Going viral: next-generation sequencing applied to phage populations in the human gut
Reyes, A., Semenkovich, N. P., Whiteson, K., Rohwer, F., & Gordon, J. I. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2853 · Cited by 441
Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases
Matsuzaki, S., Rashel, M., Uchiyama, J., Sakurai, S., Ujihara, T., Kuroda, M., Imai, S., Ikeuchi, M., Tani, T., Fujieda, M., et al. (2005) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-005-0408-9 · Cited by 409
Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
Van Belleghem, J. D., Dąbrowska, K., Vaneechoutte, M., Barr, J. J., & Bollyky, P. L. (2018) · Viruses · doi:10.3390/v11010010 · Cited by 408
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Considerations for the Use of Phage Therapy in Clinical Practice
Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-21 · Cited by 378
Dąbrowska, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21572 · Cited by 375
Therapeutic strategies to combat antibiotic resistance
Brooks, B. D., & Brooks, A. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.027 · Cited by 367
Rebuilding the Gut Microbiota Ecosystem
Gagliardi, A., Totino, V., Cacciotti, F., Iebba, V., Neroni, B., Bonfiglio, G., Trancassini, M., Passariello, C., Pantanella, F., & Schippa, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081679 · Cited by 340
Bacteriophage Endolysins as a Novel Class of Antibacterial Agents
Borysowski, J., Weber-Dąbrowska, B., & Górski, A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100402 · Cited by 338
Statistical structure of host–phage interactions
Flores, C. O., Meyer, J. R., Valverde, S., Farr, L., & Weitz, J. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101595108 · Cited by 327
Touchon, M., Moura de Sousa, J. A., & Rocha, E. P. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.04.010 · Cited by 324
Evolution in Health and Disease
(2007) · doi:10.1093/acprof:oso/9780199207466.001.0001 · Cited by 320
Biotechnological applications of bacteriophages: State of the art
Harada, L. K., Silva, E. C., Campos, W. F., Del Fiol, F. S., Vila, M., Dąbrowska, K., Krylov, V. N., & Balcão, V. M. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.04.007 · Cited by 318
Evolutionary Rationale for Phages as Complements of Antibiotics
Torres-Barceló, C., & Hochberg, M. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.011 · Cited by 308
Mammalian Host-Versus-Phage immune response determines phage fate in vivo
Hodyra-Stefaniak, K., Miernikiewicz, P., Drapała, J., Drab, M., Jończyk-Matysiak, E., Lecion, D., Kaźmierczak, Z., Beta, W., Majewska, J., Harhala, M., et al. (2015) · Scientific Reports · doi:10.1038/srep14802 · Cited by 302
Recent progress in fluorescent probes for bacteria
Huang, Y., Chen, W., Chung, J., Yin, J., & Yoon, J. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01340d · Cited by 299
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Phage combination therapies for bacterial wilt disease in tomato
Wang, X., Wei, Z., Yang, K., Wang, J., Jousset, A., Xu, Y., Shen, Q., & Friman, V.-P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0328-3 · Cited by 291
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Kunz Coyne, A. J., El Ghali, A., Holger, D., Rebold, N., & Rybak, M. J. (2022) · Infectious Diseases and Therapy · doi:10.1007/s40121-022-00591-2 · Cited by 275
Finding alternatives to antibiotics
Allen, H. K., Trachsel, J., Looft, T., & Casey, T. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12468 · Cited by 269
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Luong, T., Salabarria, A.-C., & Roach, D. R. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.07.014 · Cited by 266
Alternatives to overcoming bacterial resistances: State-of-the-art
Rios, A. C., Moutinho, C. G., Pinto, F. C., Del Fiol, F. S., Jozala, A., Chaud, M. V., Vila, M. M. D. C., Teixeira, J. A., & Balcão, V. M. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.04.008 · Cited by 263
Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota
Mills, S., Shanahan, F., Stanton, C., Hill, C., Coffey, A., & Ross, R. P. (2013) · Gut Microbes · doi:10.4161/gmic.22371 · Cited by 261
Phenotypic Resistance and the Dynamics of Bacterial Escape from Phage Control
Bull, J. J., Vegge, C. S., Schmerer, M., Chaudhry, W. N., & Levin, B. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094690 · Cited by 123
Self-citationAIEgens for microbial detection and antimicrobial therapy
Bai, H., He, W., Chau, J. H. C., Zheng, Z., Kwok, R. T. K., Lam, J. W. Y., & Tang, B. Z. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120598 · Cited by 130
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18081115 · Cited by 56
Nanomedicine for phage therapy: Encapsulation strategies for enhanced antimicrobial efficacy
Dorta-Gorrín, A., Salgueiriño, V., & García-Hevia, L. (2026) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107660 · Cited by 16
Metadata
- Authors
- Levin, B. R., & Bull, J. J.
- Venue
- Nature Reviews Microbiology
- Published
- 2004-02
- Volume
- 2
- Issue
- 2
- Pages
- 166-173
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2159445822
- Cited by
- 511
- References
- 56
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.